Stimulation of mast cells via FcεR1 and TLR2: The type of ligand determines the outcome

Molecular Immunology

Volumn 44, Issue 8, 2007, Pages 2087-2094

  Fehrenbach, Kerstin ^a   Port, Fillip ^a   Grochowy, Gordon ^a   Kalis, Christoph ^a   Bessler, Wolfgang ^a   Galanos, Chris ^b   Krystal, Gerald ^c   Freudenberg, Marina ^b   Huber, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Antigen; Calcium mobilization; Degranulation; Fc R1; IL 6; Lipopeptides; MALP 2; Pam3CSK4; TLR2

Indexed keywords

2,4 DINITROPHENOL; BACTERIAL PROTEIN; FC RECEPTOR; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 6; LIGAND; LIPOPEPTIDE; MYCOPLASMA DERIVED MACROPHAGE ACTIVATING LIPOPEPTIDE; N PALMITOYL [2,3 BIS(PALMITOYLOXY)PROPYL]CYSTEINYLSERYLLYSYLLYSYLLYSINE; TOLL LIKE RECEPTOR 2; BACTERIAL ANTIGEN; CYTOKINE; OLIGOPEPTIDE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRICITY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HYPERSENSITIVITY; IMMUNOLOGY; INFECTION; PHOSPHORYLATION;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BONE MARROW CELLS; CALCIUM SIGNALING; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFECTION; LIGANDS; MALE; MAST CELLS; MICE; MODELS, IMMUNOLOGICAL; OLIGOPEPTIDES; PHOSPHORYLATION; RECEPTORS, IGE; TOLL-LIKE RECEPTOR 2;

EID: 37849187487     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.09.011     Document Type: Article

References (31)

1. Costa J.J., Weller P.F., and Galli S.J. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278 (1997) 1815-1822
2. Eshhar Z., Ofarim M., and Waks T. Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity. J. Immunol. 124 (1980) 775-780
3. Galanos C., Gumenscheimer M., Muhlradt P., Jirillo E., and Freudenberg M. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?. J. Endotoxin Res. 6 (2000) 471-476
4. Gilman A.G., Simon M.I., Bourne H.R., Harris B.A., Long R., Ross E.M., Stull J.T., Taussig R., Bourne H.R., Arkin A.P., Cobb M.H., Cyster J.G., Devreotes P.N., Ferrell J.E., Fruman D., Gold M., Weiss A., Stull J.T., Berridge M.J., Cantley L.C., Catterall W.A., Coughlin S.R., Olson E.N., Smith T.F., Brugge J.S., Botstein D., Dixon J.E., Hunter T., Lefkowitz R.J., Pawson A.J., Sternberg P.W., Varmus H., Subramaniam S., Sinkovits R.S., Li J., Mock D., Ning Y., Saunders B., Sternweis P.C., Hilgemann D., Scheuermann R.H., DeCamp D., Hsueh R., Lin K.M., Ni Y., Seaman W.E., Simpson P.C., O'Connell T.D., Roach T., Simon M.I., Choi S., Eversole-Cire P., Fraser I., Mumby M.C., Zhao Y., Brekken D., Shu H., Meyer T., Chandy G., Heo W.D., Liou J., O'Rourke N., Verghese M., Mumby S.M., Han H., Brown H.A., Forrester J.S., Ivanova P., Milne S.B., Casey P.J., Harden T.K., Arkin A.P., Doyle J., Gray M.L., Meyer T., Michnick S., Schmidt M.A., Toner M., Tsien R.Y., Natarajan M., Ranganathan R., and Sambrano G.R. Overview of the alliance for cellular signaling. Nature 420 (2002) 703-706
5. Gimborn K., Lessmann E., Kuppig S., Krystal G., and Huber M. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J. Immunol. 174 (2005) 507-516
6. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., and Krystal G. The Src homology 2-containing inositol phosphatase (Ship) is the gatekeeper of mast cell degranulation. Proc. Nat. Acad. Sci. U.S.A. 95 (1998) 11330-11335
7. Huber M., Helgason C.D., Scheid M.P., Duronio V., Humphries R.K., and Krystal G. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J. 17 (1998) 7311-7319
8. Huber M., Kalis C., Keck S., Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Beutler B., Galanos C., and Freudenberg M. R-form LPS, the master key to the activation of TLR4/MD2 positive cells. Eur. J. Immunol. 36 (2006) 701-711
9. Jumaa H., Wollscheid B., Mitterer M., Wienands J., Reth M., and Nielsen P.J. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11 (1999) 547-554
10. Karasuyama H., and Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18 (1988) 97-104
11. Kim K.M., and Reth M. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J. Exp. Med. 181 (1995) 1005-1014
12. Kraft M., Cassell G.H., Henson J.E., Watson H., Williamson J., Marmion B.P., Gaydos C.A., and Martin R.J. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158 (1998) 998-1001
13. Liu L., Damen J.E., Cutler R.L., and Krystal G. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Mol. Cell. Biol. 14 (1994) 6926-6935
14. Malcolm A.J., Holford-Strevens V., and Sehon A.H. The effect of hapten-specific suppression of IgE on antigen-induced histamine release from mouse peritoneal mast cells. Int. Arch. Allergy Appl. Immunol. 59 (1979) 286-297
15. Manukyan M., Triantafilou K., Triantafilou M., Mackie A., Nilsen N., Espevik T., Wiesmuller K.H., Ulmer A.J., and Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 35 (2005) 911-921
16. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 (2004) 787-799
17. Martin R.J., Kraft M., Chu H.W., Berns E.A., and Cassell G.H. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107 (2001) 595-601
18. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170 (2003) 1625-1629
19. Minguet S., Huber M., Rosenkranz L., Schamel W.W., Reth M., and Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappaB pathway downstream of immunoreceptors. Eur. J. Immunol. 35 (2005) 31-41
20. Muroi M., Ohnishi T., Azumi-Mayuzumi S., and Tanamoto K. Lipopolysaccharide-mimetic activities of a Toll-like receptor 2-stimulatory substance(s) in enterobacterial lipopolysaccharide preparations. Infect. Immun. 71 (2003) 3221-3226
21. Pracht C., Gimborn K., Reth M., and Huber M. BCR mutants deficient in ligand-independent and more sensitive for ligand-dependent signaling. Eur. J. Immunol. 32 (2002) 1614-1620
22. Qiao H., Andrade M.V., Lisboa F.A., Morgan K., and Beaven M.A. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107 (2006) 610-618
23. Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., and Raz E. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172 (2004) 2739-2743
24. Reth M., Hammerling G.J., and Rajewsky K. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Eur. J. Immunol. 8 (1978) 393-400
25. Seifert R., Schultz G., Richter-Freund M., Metzger J., Wiesmuller K.H., Jung G., Bessler W.G., and Hauschildt S. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides. Biochem. J. 267 (1990) 795-802
26. Sonoda E., Pewzner-Jung Y., Schwers S., Taki S., Jung S., Eilat D., and Rajewsky K. B cell development under the condition of allelic inclusion. Immunity 6 (1997) 225-233
27. Takeda K., and Akira S. Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 34 (2004) 73-82
28. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., and Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13 (2001) 933-940
29. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169 (2002) 10-14
30. van Toorenenbergen A.W., van Swieten P., and Aalberse R.C. Measurement of IgE on rat mast cells: relation to serum IgE and allergen-induced histamine release. Scand. J. Immunol. 17 (1983) 13-18
31. von Hertzen L.C. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann. Med. 30 (1998) 27-37